ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...

The global cystic fibrosis therapeutics market size is calculated at USD 11.81 billion in 2025 and is expected to reach ...

New research from the Arnold School's Department of Epidemiology and Biostatistics has found disparities in mortality rates ...

Organizers of the University of Manitoba’s edition of the Shinerama fundraiser are pictured recently. The students will be ...

D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene ...

This Friday, October 3rd, the Cystic Fibrosis Foundation will host its Little Rock Finest event at 6:30 p.m. in Argenta Plaza, bringing together the best of the ...

Tory MP Richard Holden said the NHS should ‘stop taking the knee to damaging and oppressive cultural practices’ ...

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

UK’s National Health Service (NHS) is facing criticism for linking first-cousin marriages to “stronger extended family ...

From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and ...

A NHS report on first-cousin marriage renewed debate over cultural sensitivity versus health concerns before being removed ...

Some leading organizations in the field of cell and gene therapies recently issued a call for a 10-year international moratorium delay on the use of CRISPR. That's the scissoring techniques used to ...